BTSG BrightSpring (BTSG) Q2 FY26 earnings call
BrightSpring Health Services reported a strong second quarter, surpassing expectations with robust revenue and EBITDA growth across its Pharmacy Solutions and Provider Services segments. The company demonstrated effective operational execution, leveraging scale and technology to drive profitability and reduce leverage. Despite ongoing IRA headwinds impacting Home and Community Pharmacy revenue, management remains confident in its full-year guidance and strategic growth initiatives, including disciplined M&A and expansion into new markets.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
BTSG operating KPIs by quarter
| KPI | Mar 2026 Q1 FY26 | This call Jun 2026 Q2 FY26 | Change vs prior quarter |
|---|---|---|---|
| LDDs | 153We continue to see strong volume performance from both brand LDDs and generics, and we added 4 exclusive and UltraAR LDDs to our portfolio in the first quarter, bringing our total number of LDDs to 153.Source: earnings call transcript | 155During the quarter, we added 2 ultra-narrow network LDDs to our portfolio bringing the total number of LDDs to 155.Source: earnings call transcript | +1.3% |
Operating figures the company stated on at least two of the calls shown, checked against each call's transcript. Click a figure to read the sentence. A dash means it was not stated that quarter.
Inve summary of the company's earnings call; see how call summaries are prepared. Not investment advice.